IAM
AVBP icon

Infinitum Asset Management’s ArriVent BioPharma AVBP Stock Holding History

Infinitum Asset Management’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$154M Buy
4,438,384
+289,461
+7% +$8.54M 15.68% 2
2026
Q1 		$95.7M Buy
4,148,923
+25,000
+0.6% +$565K 11.95% 2
2025
Q4 		$83M Buy
4,123,923
+255,000
+7% +$5.31M 12.28% 2
2025
Q3 		$71.4M Buy
3,868,923
+450,000
+13% +$8.84M 13.13% 2
2025
Q2 		$74.4M Buy
3,418,923
+1,352,685
+65% +$28.1M 16.48% 2
2025
Q1 		$38.2M Buy
2,066,238
+422,315
+26% +$10.3M 12.22% 2
2024
Q4 		$43.8M Buy
+1,643,923
New +$47.2M 23.15% 2

Other funds holding AVBP

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Infinitum Asset Management's AVBP Position: Q2 2026 in Review

Infinitum Asset Management increased its ArriVent BioPharma (AVBP) stake by 7% in Q2 2026, buying an estimated $8.54M and bringing the position to 4,438,384 shares worth $154M. The position accounts for 15.68% of the portfolio, ranked #2.

Infinitum Asset Management first reported a position in AVBP in Q4 2024 and has held it in 7 quarters since. 158 funds tracked by Wall St. Rank hold AVBP as of Q2 2026.

  • Infinitum Asset Management held 4,438,384 shares of ArriVent BioPharma worth $154M as of Q2 2026.
  • Infinitum Asset Management bought 289,461 ArriVent BioPharma shares in Q2 2026, an estimated $8.54M.
  • ArriVent BioPharma made up 15.68% of Infinitum Asset Management's portfolio in Q2 2026, its #2 holding.
  • Infinitum Asset Management first reported a position in ArriVent BioPharma in Q4 2024 and has held it in 7 quarters since.
  • 158 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q2 2026.

Based on Infinitum Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.